UpHealth (UPHL) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 02, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	GigCapital2, Inc.
Entity Central Index Key	0001770141
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		22,245,000
Entity Shell Company	true
Entity File Number	001-38924
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-3838045
Entity Address, Address Line One	1731 Embarcadero Rd.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Palo Alto
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94303
City Area Code	(650)
Local Phone Number	276-7040
Document Quarterly Report	true
Document Transition Report	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Common Stock, one Right and one Warrant
Trading Symbol	GIX.U
Security Exchange Name	NYSE
Units
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	GIX
Security Exchange Name	NYSE
Rights to Purchase One-twentieth of One Share of Common Stock
Document Information [Line Items]
Title of 12(b) Security	Rights to purchase one-twentieth of one share of Common Stock
Trading Symbol	GIX.RT
Security Exchange Name	NYSE
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase one share of Common Stock
Trading Symbol	GIX.WS
Security Exchange Name	NYSE

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash	$ 387,430	$ 1,576,508
Prepaid expenses	178,047	161,609
Receivable from related parties	10,078	1,952
Total current assets	575,555	1,740,069
Cash and marketable securities held in Trust Account	174,284,387	173,994,583
Other non-current assets		33,327
TOTAL ASSETS	174,859,942	175,767,979
Current liabilities
Accounts payable	24,597	142,613
Payable to related parties	6,185	16,649
Accrued liabilities	150
Other current liabilities		180,696
Total liabilities	30,932	339,958
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 16,982,900 and 17,042,802 shares as of September 30, 2020 and December 31, 2019, respectively, at a redemption value of $10.00 per share	169,829,000	170,428,020
Stockholders’ equity
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 5,262,100 and 5,202,198 shares issued and outstanding as of September 30, 2020 and December 31, 2019	526	520
Additional paid-in capital	5,238,044	4,639,030
Retained earnings (accumulated deficit)	(238,560)	360,451
Total stockholders’ equity	5,000,010	5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 174,859,942	$ 175,767,979

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common stock subject to possible redemption, shares	16,982,900	17,042,802
Common stock subject to possible redemption value per share	$ 10	$ 10
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	5,262,100	5,202,198
Common stock, shares outstanding	5,262,100	5,202,198

Condensed Statements of Operati

Condensed Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2020
Income Statement [Abstract]
General and administrative expenses	$ 361,005	$ 395,583	$ 577,407	$ 1,346,525
Loss from operations	(361,005)	(395,583)	(577,407)	(1,346,525)
Other income
Interest income on cash and marketable securities held in Trust Account	44,890	933,853	1,151,957	1,016,923
Income (loss) before provision for income taxes	(316,115)	538,270	574,550	(329,602)
Provision for income taxes	14,119	278,662	343,744	269,409
Net income (loss) and comprehensive income (loss)	(330,234)	259,608	230,806	(599,011)
Net loss attributable to common stockholders	$ (353,726)	$ (241,866)	$ (387,789)	$ (1,169,699)
Weighted-average common shares outstanding, basic and diluted	5,245,947	5,223,704	4,675,325	5,218,968
Net loss per share common share, basic and diluted	$ (0.07)	$ (0.05)	$ (0.08)	$ (0.22)

Condensed Statements of Stockho

Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	IPO	Private Placement	Underwriters	Common Stock	Common StockIPO	Common StockPrivate Placement	Common StockUnderwriters	Additional Paid-in Capital	Additional Paid-in CapitalIPO	Additional Paid-in CapitalPrivate Placement	Additional Paid-in CapitalUnderwriters	Retained Earnings (Accumulated Deficit)
Balance at Mar. 05, 2019	$ 0				$ 0				$ 0				$ 0
Balance, Shares at Mar. 05, 2019					0
Sale of common stock	25,000	$ 168,167,570	$ 5,675,000	$ 1,200,000	$ 431	$ 1,725	$ 57	$ 12	24,569	$ 168,165,845	$ 5,674,943	$ 1,199,988
Sale of common stock, Shares					4,307,500	17,250,000	567,500	120,000
Issuance of insider shares for no consideration					$ 1				(1)
Issuance of Insider shares for no consideration, Shares					5,000
Cancellation of insider shares					$ (1)				1
Cancellation of insider shares, Shares					(5,000)
Shares subject to redemption	(170,298,370)				$ (1,703)				(170,296,667)
Shares subject to redemption, Shares					(17,029,837)
Net income (loss)	230,806												230,806
Balance at Sep. 30, 2019	5,000,006				$ 522				4,768,678				230,806
Balance, Shares at Sep. 30, 2019					5,215,163
Balance at Jun. 30, 2019	5,000,008				$ 524				5,028,286				(28,802)
Balance, Shares at Jun. 30, 2019					5,237,624
IPO offering costs		$ (85,000)								$ (85,000)
Cancellation of insider shares					$ (1)				1
Cancellation of insider shares, Shares					(5,000)
Shares subject to redemption	(174,610)				$ (1)				(174,609)
Shares subject to redemption, Shares					(17,461)
Net income (loss)	259,608												259,608
Balance at Sep. 30, 2019	5,000,006				$ 522				4,768,678				230,806
Balance, Shares at Sep. 30, 2019					5,215,163
Balance at Dec. 31, 2019	$ 5,000,001				$ 520				4,639,030				360,451
Balance, Shares at Dec. 31, 2019	5,202,198				5,202,198
Issuance of Insider shares for no consideration, Shares	5,000
IPO offering costs	$ (4,332,430)
Shares subject to redemption	599,020				$ 6				599,014
Shares subject to redemption, Shares					59,902
Net income (loss)	(599,011)												(599,011)
Balance at Sep. 30, 2020	$ 5,000,010				$ 526				5,238,044				(238,560)
Balance, Shares at Sep. 30, 2020	5,262,100				5,262,100
Balance at Jun. 30, 2020	$ 5,000,004				$ 523				4,907,807				91,674
Balance, Shares at Jun. 30, 2020					5,229,076
Shares subject to redemption	330,240				$ 3				330,237
Shares subject to redemption, Shares					33,024
Net income (loss)	(330,234)												(330,234)
Balance at Sep. 30, 2020	$ 5,000,010				$ 526				$ 5,238,044				$ (238,560)
Balance, Shares at Sep. 30, 2020	5,262,100				5,262,100

Condensed Statements of Stock_2

Condensed Statements of Stockholders' Equity (Deficit) (Parenthetical) (Unaudited)	Sep. 30, 2019$ / shares
Founders
Sale of common stock price per share	$ 0.005804
Private Placement | Founders
Sale of common stock price per share	10
Underwriters
Sale of common stock price per share	$ 10

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020
OPERATING ACTIVITIES
Net income (loss)	$ 230,806	$ (599,011)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(1,151,957)	(1,016,923)
Change in operating assets and liabilities:
Prepaid expenses	(187,100)	(16,438)
Receivable from related parties	(30,054)	(8,126)
Other non-current assets	(53,368)	33,327
Accounts payable	96,632	(118,016)
Payable to related parties		(10,464)
Accrued liabilities	5,000	150
Other current liabilities	293,362	(180,696)
Net cash and cash equivalents used in operating activities	(796,679)	(1,916,197)
INVESTING ACTIVITIES
Investment of cash in Trust Account	(172,500,000)
Cash withdrawn from Trust Account	71,590	727,119
Net cash and cash equivalents provided by (used in) investing activities	(172,428,410)	727,119
FINANCING ACTIVITIES
Proceeds from sale of common stock to Founders	25,000
Borrowing from related party	99,937
Repayment of borrowing from related party	(99,937)
Proceeds from sale of Private Placement Units	5,675,000
Proceeds from sale of common stock to underwriters	1,200,000
Proceeds from sale of Units, net of underwriting discounts paid	169,050,000
Payment of offering costs	(689,210)
Net cash and cash equivalents provided by financing activities	175,260,790
Net change in cash and cash equivalents during period	2,035,701	(1,189,078)
Cash and cash equivalents, beginning of period		1,576,508
Cash and cash equivalents, end of period	2,035,701	387,430
SUPPLEMENTAL DISCLOSURES
Cash paid for income taxes	50,382	462,238
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Offering costs included in accounts payable	193,220
Change in value of common stock subject to possible redemption	$ 2,130,800	$ (599,020)

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization and Business Operations	1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Organization and General GigCapital2, Inc. (the “Company”) was incorporated in Delaware on March 6, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of September 30, 2020, the Company had not commenced any operations. All activity for the period from March 6, 2019 (date of inception) through September 30, 2020 relates to the Company’s formation and the initial public offering (the “Offering”), as described in Note 3, and identifying a target Business Combination, as described below. The Company will not generate any operating revenues until after completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor, GigAcquisitions2, LLC, a Delaware limited liability company (the “Sponsor”), together with one of the underwriters, EarlyBirdCapital, Inc. (“EarlyBird”) and certain affiliates and employees of EarlyBird (the “EarlyBird Group”), and Northland Gig 2 Investment LLC, a Delaware limited liability company (“Northland Investment”) collectively make up the founders of the Company (the “Founders”). On June 5, 2019, the initial registration statement on Form S-1, as amended, filed in connection with the Offering, and the subsequent registration statement on Form S-1 filed by the Company pursuant to Section 462(b) of the Securities Act to register additional securities, also in connection with the Offering, were declared effective. The Company concurrently entered into an underwriting agreement on June 5, 2019 to conduct the Offering, the initial closing of which was consummated on June 10, 2019 with the delivery of 15,000,000 units (the “Units”). The Units sold in the Offering consisted of the securities described in Note 3. The Offering generated gross proceeds of $150,000,000. Simultaneously with the initial closing of the Offering, the Company consummated the initial closing of a private placement sale (the “Private Placement”) of 492,500 units (the “Private Placement Units”), at a price of $10.00 per unit, to its Founders, and 100,000 shares of its common stock (the “Private Underwriter Shares”), at a price of $10.00 per share, to Northland Securities, Inc. (“Northland”), an affiliate of Northland Investment. The Private Placement Units consisted of the securities described in Note 4. The initial closing of the Private Placement generated gross proceeds of $5,925,000. Following the initial closing of the Offering, net proceeds in the amount of $147,000,000 from the sale of the Units and proceeds in the amount of $3,000,000 from the sale of Private Placement Units, for a total of $150,000,000, were placed in a trust account (“Trust Account”) which is described further below. On June 13, 2019, in connection with the underwriters’ exercise in full of their option to purchase an additional 2,250,000 Units solely to cover over-allotments, if any (the “over-allotment option”), the Company consummated the sale of an additional 2,250,000 Units at $10.00 per unit. Simultaneously with the closing of the sale of the additional Units, the Company consummated a second closing of the Private Placement, resulting in the sale of an additional 75,000 Private Placement Units at $10.00 per unit to the Founders, and an additional 20,000 Private Underwriter Shares at $10.00 per share to Northland. Following the closings, an additional $22,500,000 of net proceeds were placed in the Trust Account. Transaction costs amounted to $4,332,430, consisting of $3,450,000 of underwriting fees and $882,430 of offering costs. The Company’s remaining cash after payment of the offering costs will be held outside of the Trust Account for working capital purposes. The Trust Account The funds in the Trust Account have been invested only in U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government obligations. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Business Combination or (ii) the distribution of the Trust Account as described below. The remaining proceeds from the Offering outside the Trust Account may be used to pay for business, legal and accounting due diligence expenses on acquisition targets and continuing general and administrative expenses. The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of 100% of the shares of common stock included in the units sold in the Offering (the “public shares”) if the Company is unable to complete a Business Combination within 18 months from the closing of the Offering on June 10, 2019; or (iii) the redemption of the public shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if it does not complete its initial Business Combination within 18 months from the closing of the Offering on June 10, 2019. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Offering, although substantially all of the net proceeds of the Offering are intended to be The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable or (ii) provide stockholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to commencement of the tender offer, including interest but less taxes payable. The decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to redeem their shares to the Company in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by New York Stock Exchange rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares and the related Business Combination, and instead may search for an alternate Business Combination. If the Company holds a stockholder vote or there is a tender offer for shares in connection with a Business Combination, a public stockholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable. As a result, such shares of common stock have been recorded at their redemption amount and classified as temporary equity. The amount held in the Trust Account as of September 30, 2020 was $174,284,387 which represents cash and marketable securities of $172,500,000 from the sale of 17,250,000 Units at $10.00 per unit and $2,889,624 of interest income earned on these holdings, less $1,105,237 withdrawn from the interest earned on the Trust Account to pay tax obligations. The Company will have 18 months from June 10, 2019, the closing date of the Offering, to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of common stock for a per share pro rata portion of the Trust Account, including interest, but less taxes payable (less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining stockholders, as part of its plan of dissolution and liquidation. The Founders, Northland and the Company’s former Chief Financial Officer, Ms. McDonough, who received 5,000 shares of common stock (the “insider shares”), have entered into letter agreements with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their initial shares; however, if the Founders, Northland or Ms. McDonough or any of the Company’s officers, directors or affiliates acquired shares of common stock after the Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the required time period. As a result of Ms. McDonough’s resignation effective as of August 12, 2019, Ms. McDonough forfeited her insider shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per unit.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020, and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2019 as filed with SEC on March 30, 2020, which contains the audited financial statements and notes thereto. The condensed financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. As of September 30, 2020, the Company had $387,430 in cash and working capital of $544,623. Further, the Company expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company plans to address this uncertainty by raising additional capital and/or completing its Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful or successful within the target business acquisition period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised accounting standard at the time private companies adopt the new or revised standard. Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating the net loss per common share. Shares of common stock subject to possible redemption as of September 30, 2020 have been excluded from the calculation of the basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. When calculating its diluted net loss per share, the Company has not considered the effect of (i) the incremental number of shares of common stock to settle warrants sold in the Offering and Private Placement, as calculated using the treasury stock method; (ii) the contingently issuable shares associated with the rights sold in the Offering and Private Placement to receive one-twentieth (1/20) of one share of common stock upon the consummation of the Company’s initial Business Combination; and (iii) the insider shares issued to the former Chief Financial Officer representing 5,000 shares of common stock underlying restricted stock awards for the period they were outstanding. Since the Company was in a net loss position during the periods after deducting net income attributable to common stock subject to redemption, diluted net loss per common share is the same as basic net loss per common share for the periods presented as the inclusion of all potential common shares outstanding would have been anti-dilutive. Reconciliation of Net Loss Per Common Share In accordance with the two-class method, the Company’s net income (loss) is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 For the Three Months Ended September 30, 2019 For the Nine Months Ended September 30, 2020 Period from March 6, 2019 (Inception) through September 30, 2019 Net income (loss) $ (330,234 ) $ 259,608 $ (599,011 ) $ 230,806 Less: net income attributable to common stock subject to redemption (23,492 ) (501,474 ) (570,688 ) (618,595 ) Net loss attributable to common stockholders $ (353,726 ) $ (241,866 ) $ (1,169,699 ) $ (387,789 ) Weighted-average common shares outstanding, basic and diluted 5,245,947 5,223,704 5,218,968 4,675,325 Net loss per share common share, basic and diluted $ (0.07 ) $ (0.05 ) $ (0.22 ) $ (0.08 ) Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions. Cash and Marketable Securities Held in Trust Account As of September 30, 2020, the assets held in the Trust Account consisted of money market funds and cash. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the condensed balance sheets primarily due to their short-term nature. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Offering Costs Offering costs in the amount of $4,332,430 consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Offering. Offering costs were charged to stockholders’ equity and recorded in additional paid-in capital as a reduction to the gross proceeds received upon completion of the Offering. Common Stock Subject to Possible Redemption Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2020 , common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet s . Stock-based Compensation Stock-based compensation related to restricted stock awards are based on fair value of common stock on the grant date. The shares underlying the Company’s restricted stock awards are subject to forfeiture if these individuals resign or are terminated for cause prior to the completion of the Business Combination. Therefore, the related stock-based compensation will be recognized upon the completion of a Business Combination, unless the related shares are forfeited prior to a Business Combination occurring. Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The amount paid for interest and penalties during the quarter ended September 30, 2020 was $724, which was related to 2019 income taxes. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements The Company does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Offering

Offering	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Offering	3. OFFERING On June 10, 2019, the Company completed the initial closing of the Offering whereby the Company sold 15,000,000 Units at a price of $10.00 per Unit. On June 13, 2019, the Company completed the second closing of the Offering with the exercise of the over-allotment option with the consummation of the sale of an additional 2,250,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of the Company’s common stock, $0.0001 par value, one warrant to purchase one share of common stock (the “Warrants”), and one right to receive one-twentieth ( 1/20 On June 26, 2019, the Company announced that the holders of the Company’s Units may elect to separately trade the securities underlying such Units which commenced on July 1, 2019. Any Units not separated will continue to trade on the New York Stock Exchange under the symbol “GIX.U”. Any underlying shares of common stock, Warrants and Rights that are separated will trade on the New York Stock Exchange under the symbols “GIX,” “GIX WS” and “GIX RT,” respectively.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	4. RELATED PARTY TRANSACTIONS Founder Shares During the period from March 6, 2019 (date of inception) to March 12, 2019, the Sponsor and Northland Investment purchased 2,500,000 shares of common stock (the “Founder Shares”) for an aggregate purchase price of $25,000, or $0.01 per share. In April 2019, the Company effected a stock dividend of 0.493 shares of common stock for each outstanding share of common stock, resulting in the Sponsor and Northland Investment holding an aggregate of 3,732,500 shares of its common stock. Subsequently, the Sponsor and Northland Investment sold 68,041 shares and 31,959 shares, respectively, to EarlyBird and the EarlyBird Group collectively for an aggregate purchase price of $670 EarlyBird Group holding an aggregate of 4,307,500 shares of its common stock as of September 30, 2020 . The Founder Shares are identical to the common stock included in the Units sold in the Offering except that the Founder Shares are subject to certain transfer restrictions, as described in more detail below . Private Placement The Founders purchased from the Company an aggregate of 492,500 Private Placement Units at a price of $10.00 per unit in a private placement that occurred simultaneously with the completion of the initial closing of the Offering. The Founders also purchased from the Company an aggregate of 75,000 Private Placement Units at a price of $10.00 per unit in a private placement that occurred simultaneously with the completion of the second closing of the Offering with the exercise of the over-allotment option. Among the Private Placement Units, 481,250 units were purchased by the Sponsor, 29,900 units were purchased by EarlyBird, and 56,350 units were purchased by Northland Investment. Each Private Placement Unit consists of one share of the Company’s common stock, $0.0001 par value, one Warrant, and one right to receive one-twentieth (1/20) One of the Company’s underwriters, Northland, purchased 100,000 Private Underwriter Shares, at a purchase price of $10.00 per share in a private placement that occurred simultaneously with the completion of the initial closing of the Offering. Northland also purchased from the Company an aggregate of 20,000 Private Underwriter Shares at a price of $10.00 per share in a private placement that occurred simultaneously with the completion of the second closing of the Offering with the exercise of the over-allotment option. The Private Underwriter Shares are identical to the shares of common stock included in the Private Placement Units. The Company’s Founders and underwriters have agreed not to transfer, assign or sell any of their Founder Shares, Private Placement Units, shares or other securities underlying such Private Placement Units, or Private Underwriter Shares until the earlier of (i) twelve months after the completion of the Company’s initial Business Combination, or earlier if, subsequent to the Company’s initial Business Combination, the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 90 days after the Company’s initial Business Combination or (ii) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial Business Unlike the Warrants included in the Units sold in the Offering, if held by the original holder or its permitted transferees, the Warrants included in the Private Placement Units are not redeemable by the Company and subject to certain limited exceptions, will be subject to transfer restrictions until one year following the consummation of the Business Combination. If the Warrants included in the Private Placement Units are held by holders other than the initial holders or their permitted transferees, the Warrants included in the Private Placement Units will be redeemable by the Company and exercisable by holders on the same basis as the Warrants included in the Offering. If the Company does not complete a Business Combination, then a portion of the proceeds from the sale of the Private Placement Units and all of the proceeds from the sale of the Private Underwriter Shares will be part of the liquidating distribution to the public stockholders. Registration Rights On June 5, 2019, the Company entered into a Registration Rights Agreement with its Founders, Northland and Ms. McDonough. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. There will be no penalties associated with delays in registering the securities under the Registration Rights Agreement. Upon cancellation of Ms. McDonough’s insider shares following her resignation, effective as of August 12, 2019, she was no longer subject to the terms and conditions set forth in the Registration Rights Agreement. Underwriters Agreement The Company granted the underwriters a 45-day option to purchase up to 2,250,000 additional Units to cover any over-allotments, at the Offering price less deferred underwriting discounts and commissions. On June 13, 2019, the underwriters elected to fully exercise their over-allotment option to purchase 2,250,000 Units at a purchase price of $10.00 per unit. The Company paid an underwriting discount of $0.20 per Unit to the underwriters. Administrative Services Agreement and Other Agreements The Company agreed to pay $20,000 a month for office space, administrative services and secretarial support to an affiliate of the Sponsor, GigFounders, LLC. Services commence on June 6, 2019, the date the securities were first listed on the New York Stock Exchange and will terminate upon the earlier of the consummation by the Company of an initial Business Combination or the liquidation of the Company.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	5. COMMITMENTS AND CONTINGENCIES Business Combination Marketing Agreement The Company engaged its underwriters as advisors to assist it in holding meetings with its stockholders to discuss the potential Business Combination and the Target Business’s attributes, introduce it to potential investors that are interested in purchasing its securities in connection with the potential Business Combination, assist it in obtaining stockholder approval for the Business Combination and assist it with its press releases and public filings in connection with the Business Combination. Pursuant to that agreement, the Company will pay the underwriters a cash fee for such services upon the consummation of its initial Business Combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Offering, including any proceeds from the exercise of the over-allotment options.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity	6. STOCKHOLDERS’ EQUITY Common Stock The authorized common stock of the Company includes up to 100,000,000 shares. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of September 30, 2020, there were 5,262,100 shares of common stock issued and outstanding and not subject to possible redemption. There were 16,982,900 shares of common stock subject to possible redemption issued and outstanding as of September 30, 2020. Preferred Stock The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors (the “Board”). As of September 30, 2020, there were no shares of preferred stock issued and outstanding. Warrants Warrants will be exercisable for $11.50 per share, and the exercise price and number of Warrant shares issuable on exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation of the Company. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s Board, and in the case of any such issuance to the Company’s Founders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading-day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities. Each Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on or prior to the 18-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of common stock to the holder upon exercise of the Warrants during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the Warrant agreement. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Warrant holders. Under the terms of the Warrant agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the Company’s initial Business Combination, for the registration of the shares of common stock issuable upon exercise of the Warrants included in the Units. As of September 30, 2020, there were 17,817,500 Warrants outstanding. Rights Each holder of a right will receive one-twentieth ( 1⁄20 If the Company is unable to complete an initial Business Combination within 18 months from the closing date of the Offering and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver shares of common stock to the holders of the rights upon consummation of an initial Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. As of September 30, 2020, there were 17,817,500 rights outstanding Stock-based Compensation The 5,000 shares issued to Ms. McDonough, the Company’s former Chief Financial Officer, were forfeited upon her resignation in August 2019. Since an initial Business Combination did not occur prior to the forfeiture of these shares, no stock-based compensation expense was recorded in the Company’s condensed statements of operations and comprehensive income (loss).

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs which are supported by little or no market activity and which are significant to the fair value of the assets or liabilities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level September 30, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 174,284,387 The marketable securities held in the Trust Account are considered trading securities as they are generally used with the objective of generating profits on short-term differences in price and therefore, the realized and unrealized gain and loss are recorded in the condensed statements of operations and comprehensive income (loss) for the periods presented.

Subsequent Event

Subsequent Event	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	8. SUBSEQUENT EVENTS Recent Developments On October 27, 2020, the Company and Waste to Energy Partners LLC (dba Bolder Industries) (“Bolder Industries”) issued a joint press release announcing that the Company and Bolder Industries have entered into a non-binding letter of intent (the “Letter of Intent”) for a Business Combination. Under the terms of the Letter of Intent, the Company and Bolder Industries intend to negotiate a definitive agreement that they may enter into pursuant to which the Company would acquire Bolder Industries, with the existing equity holders of Bolder Industries receiving securities of the Company that would constitute a majority of the Company’s securities. Whether the parties enter into a definitive agreement is subject to a number of conditions, including the completion of due diligence to the Company’s satisfaction. In addition, the Company’s initial public offering (“IPO”) prospectus and Amended and Restated Certificate of Incorporations (the “Charter”), provides that the Company initially has until December 10, 2020 (the date which is 18 months after the consummation of the IPO) to complete a Business Combination. Although the Company has made substantial progress towards entering into a definitive agreement for a Business Combination, including the entry into the Letter of Intent with Bolder Industries, the Board currently believes that there will not be sufficient time before December 10, 2020 to complete a Business Combination, whether with Bolder Industries or with another company. As a result, on November 2, 2020, the Company filed a definitive proxy statement with the SEC, to invite the stockholders of the Company to attend the 2020 annual meeting (the “Annual Meeting”) to be held on December 3, 2020. At the Annual Meeting, the stockholders will vote to amend (the “Extension Amendment”) the Charter to extend the date by which the Company must consummate a Business Combination (the “Extension”) from December 10, 2020 to March 10, 2021 (the date which is 21 months from the closing date of the IPO) (the “Extended Date”). In addition, the stockholders will vote (i) to elect five directors to serve as directors on the Company’s Board until the 2021 annual meeting of stockholders or until their successors are elected and qualified; (ii) to ratify the selection of the Board’s Audit Committee of BPM LLP (“BPM”) to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2020; and (iii) to consider such other matters as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof. In connection with the Extension Amendment, if approved by the requisite vote of stockholders, public stockholders may elect to redeem their shares for a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to such approval, including interest earned on the trust account deposits (which interest shall be net of taxes payable), divided by the number of then outstanding public shares (the “Election”). However, the Company may not redeem the Company’s public shares in an amount that would cause our net tangible assets to be less than $5,000,001. If the Extension Amendment is approved by the requisite vote of stockholders, the remaining holders of public shares will retain the opportunity to have their public shares redeemed in conjunction with the consummation of a Business Combination, subject to any limitations set forth in the Company’s Charter, as amended. In addition, public stockholders who vote for the Extension Amendment and do not make the Election would be entitled to have their shares redeemed for cash if the Company has not completed a business combination by the Extended Date. The Company estimates that the per-share price at which public shares may be redeemed from cash held in the trust account will be approximately $10.10 at the time of the annual meeting. The closing price of the Company’s common stock on November 11, 2020, was $10.08. The Company cannot assure stockholders that they will be able to sell their shares of the Company’s common stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares. If the Extension Amendment proposal is not approved and the Company does not consummate a Business Combination by December 10, 2020, as contemplated by the Charter, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Board, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our rights or warrants, which will expire worthless in the event the Company winds up. The affirmative vote of 65% of the Company’s outstanding common stock will be required to approve the Extension Amendment. The Board fixed the close of business on October 26, 2020 as the record date for determining the Company’s stockholders entitled to receive notice of and vote at the annual meeting and any adjournment thereof. Only holders of record of the Company’s common stock on that date are entitled to have their votes counted at the annual meeting or any adjournment thereof.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020, and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2019 as filed with SEC on March 30, 2020, which contains the audited financial statements and notes thereto. The condensed financial information as of December 31, 2019 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. As of September 30, 2020, the Company had $387,430 in cash and working capital of $544,623. Further, the Company expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company plans to address this uncertainty by raising additional capital and/or completing its Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful or successful within the target business acquisition period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Emerging Growth Company	Emerging Growth Company Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised accounting standard at the time private companies adopt the new or revised standard.
Net Loss Per Share of Common Stock	Net Loss Per Share of Common Stock Net loss per share of common stock is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. The Company applies the two-class method in calculating the net loss per common share. Shares of common stock subject to possible redemption as of September 30, 2020 have been excluded from the calculation of the basic net loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. When calculating its diluted net loss per share, the Company has not considered the effect of (i) the incremental number of shares of common stock to settle warrants sold in the Offering and Private Placement, as calculated using the treasury stock method; (ii) the contingently issuable shares associated with the rights sold in the Offering and Private Placement to receive one-twentieth (1/20) of one share of common stock upon the consummation of the Company’s initial Business Combination; and (iii) the insider shares issued to the former Chief Financial Officer representing 5,000 shares of common stock underlying restricted stock awards for the period they were outstanding. Since the Company was in a net loss position during the periods after deducting net income attributable to common stock subject to redemption, diluted net loss per common share is the same as basic net loss per common share for the periods presented as the inclusion of all potential common shares outstanding would have been anti-dilutive. Reconciliation of Net Loss Per Common Share In accordance with the two-class method, the Company’s net income (loss) is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 For the Three Months Ended September 30, 2019 For the Nine Months Ended September 30, 2020 Period from March 6, 2019 (Inception) through September 30, 2019 Net income (loss) $ (330,234 ) $ 259,608 $ (599,011 ) $ 230,806 Less: net income attributable to common stock subject to redemption (23,492 ) (501,474 ) (570,688 ) (618,595 ) Net loss attributable to common stockholders $ (353,726 ) $ (241,866 ) $ (1,169,699 ) $ (387,789 ) Weighted-average common shares outstanding, basic and diluted 5,245,947 5,223,704 5,218,968 4,675,325 Net loss per share common share, basic and diluted $ (0.07 ) $ (0.05 ) $ (0.22 ) $ (0.08 )
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains cash balances that at times may be uninsured or in deposit accounts that exceed Federal Deposit Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account As of September 30, 2020, the assets held in the Trust Account consisted of money market funds and cash.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the condensed balance sheets primarily due to their short-term nature.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Offering Costs	Offering Costs Offering costs in the amount of $4,332,430 consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Offering. Offering costs were charged to stockholders’ equity and recorded in additional paid-in capital as a reduction to the gross proceeds received upon completion of the Offering.
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of September 30, 2020 , common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheet s .
Stock-based Payment Arrangement	Stock-based Compensation Stock-based compensation related to restricted stock awards are based on fair value of common stock on the grant date. The shares underlying the Company’s restricted stock awards are subject to forfeiture if these individuals resign or are terminated for cause prior to the completion of the Business Combination. Therefore, the related stock-based compensation will be recognized upon the completion of a Business Combination, unless the related shares are forfeited prior to a Business Combination occurring.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The Company prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The amount paid for interest and penalties during the quarter ended September 30, 2020 was $724, which was related to 2019 income taxes. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Net Loss per Common Share, Basic and Diluted	In accordance with the two-class method, the Company’s net income (loss) is adjusted for net income that is attributable to common stock subject to redemption, as these shares only participate in the income of the Trust Account and not the losses of the Company. Accordingly, net loss per common share, basic and diluted, is calculated as follows: For the Three Months Ended September 30, 2020 For the Three Months Ended September 30, 2019 For the Nine Months Ended September 30, 2020 Period from March 6, 2019 (Inception) through September 30, 2019 Net income (loss) $ (330,234 ) $ 259,608 $ (599,011 ) $ 230,806 Less: net income attributable to common stock subject to redemption (23,492 ) (501,474 ) (570,688 ) (618,595 ) Net loss attributable to common stockholders $ (353,726 ) $ (241,866 ) $ (1,169,699 ) $ (387,789 ) Weighted-average common shares outstanding, basic and diluted 5,245,947 5,223,704 5,218,968 4,675,325 Net loss per share common share, basic and diluted $ (0.07 ) $ (0.05 ) $ (0.22 ) $ (0.08 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Summary of Assets Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description: Level September 30, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 174,284,387

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Details) - USD ($)	Aug. 12, 2019	Jun. 13, 2019	Jun. 10, 2019	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019	Jun. 05, 2019
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Date of incorporation					Mar. 6, 2019
Sale of units in initial public offering					17,250,000
Sale of stock price per unit			$ 10		$ 10
Proceeds from sale of Units, net of underwriting discounts paid				$ 169,050,000
Proceeds from sale of Private Placement Units		$ 22,500,000		5,675,000
Net proceeds from sale of units			$ 150,000,000
Transaction costs		4,332,430		$ 689,210
Decommissioning trust assets description					(i) the completion of the Business Combination; (ii) the redemption of 100% of the shares of common stock included in the units sold in the Offering (the “public shares”) if the Company is unable to complete a Business Combination within 18 months from the closing of the Offering on June 10, 2019; or (iii) the redemption of the public shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if it does not complete its initial Business Combination within 18 months from the closing of the Offering on June 10, 2019.
Common stock redemption percentage					100.00%
Public shares redemption percentage					100.00%
Minimum percentage of fair market value of business acquisition to trust account balance					80.00%
Amount held in the trust account					$ 174,284,387
Cash and marketable securities					172,500,000
Interest income earned					2,889,624
Cash withdrawn from trust account interest income to pay tax obligations					$ 1,105,237
Common stock, shares issued					5,262,100	5,202,198
Chief Financial Officer
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Common stock, shares issued							5,000
Date of resignation	Aug. 12, 2019
Maximum
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Net tangible assets					$ 5,000,001
Net interest to pay dissolution expenses					$ 100,000
IPO
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units in initial public offering			15,000,000
Gross proceeds from issuance of unit			$ 150,000,000
Proceeds from sale of Units, net of underwriting discounts paid			147,000,000
Transaction costs		$ 882,430
Private Placement
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units in initial public offering		75,000
Sale of stock price per unit		$ 10
Proceeds from sale of Private Placement Units			3,000,000
Common stock held in trust			$ 150,000,000
Private Placement | Founders
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units in initial public offering			492,500
Gross proceeds from issuance of unit			$ 5,925,000
Sale of stock price per unit			$ 10
Underwriters
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units in initial public offering		20,000
Sale of stock price per unit		$ 10
Underwriters | to Northland Securities, Inc
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of units in initial public offering			100,000
Sale of stock price per unit			$ 10
Underwriters
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Sale of stock price per unit		$ 10
Common stock held in trust		$ 22,500,000
Number of additional units purchased by underwriters		2,250,000
Transaction costs		$ 3,450,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash	$ 387,430	$ 387,430	$ 1,576,508
Working capital	544,623	$ 544,623
Number of shares of common stock issued underlying restricted stock awards outstanding		5,000
Offering costs charged to stockholders' equity upon completion of offering		$ 4,332,430
Unrecognized tax benefits	0	$ 0
Amount paid for payment of interest and penalties	$ 724

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Net Loss per Common Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		7 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2020
Earnings Per Share [Abstract]
Net income (loss)	$ (330,234)	$ 259,608	$ 230,806	$ (599,011)
Less: net income attributable to common stock subject to redemption	(23,492)	(501,474)	(618,595)	(570,688)
Net loss attributable to common stockholders	$ (353,726)	$ (241,866)	$ (387,789)	$ (1,169,699)
Weighted-average common shares outstanding, basic and diluted	5,245,947	5,223,704	4,675,325	5,218,968
Net loss per share common share, basic and diluted	$ (0.07)	$ (0.05)	$ (0.08)	$ (0.22)

Offering - Additional Informati

Offering - Additional Information (Details) - $ / shares	Jun. 13, 2019	Jun. 10, 2019	Sep. 30, 2020	Dec. 31, 2019
Class Of Stock [Line Items]
Units sold in offering		15,000,000
Sale of stock price per unit		$ 10	$ 10
Number of shares of common stock per unit		1
Common stock, par value		$ 0.0001	0.0001	$ 0.0001
Second Closing of Offering
Class Of Stock [Line Items]
Units sold in offering	2,250,000
Sale of stock price per unit	$ 10
Warrants
Class Of Stock [Line Items]
Exercise price of warrants		$ 11.50	$ 11.50
Rights | Warrants
Class Of Stock [Line Items]
Number of shares of common stock each		0.20

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Jun. 13, 2019	Jun. 10, 2019	Mar. 12, 2019	Jun. 30, 2019	Apr. 30, 2019	Jun. 30, 2019	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Sale of common stock, Shares		15,000,000
Proceeds from sale of common stock to Founders							$ 25,000
Aggregate number of shares issued								17,250,000
Sale of stock price per unit		$ 10						$ 10
Number of shares of common stock per unit		1
Common stock, par value		$ 0.0001						$ 0.0001	$ 0.0001
Holding period of shares for completion of initial business combination								12 months
Number of trading period for transfer of shares								20 days
Number of consecutive trading period for transfer of shares								30 days
Underwriters option period								45 days
Paid an underwriting discount	$ 0.20
Maximum
Related Party Transaction [Line Items]
Period after initial business combination to allow transfer of shares								90 days
Warrants
Related Party Transaction [Line Items]
Exercise price of warrants		$ 11.50						$ 11.50
Warrants | Maximum
Related Party Transaction [Line Items]
Exercise price of warrants								9.50
Warrants | Rights
Related Party Transaction [Line Items]
Right to receive common stock		0.20
Common Stock
Related Party Transaction [Line Items]
Sale of common stock, Shares							4,307,500
Stock price threshold that allows transfer of shares								12.50
Common Stock | Maximum
Related Party Transaction [Line Items]
Exercise price of warrants								$ 9.50
Common Stock | Rights
Related Party Transaction [Line Items]
Right to receive common stock								0.05
Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued	75,000
Sale of stock price per unit	$ 10
Private Placement | Rights
Related Party Transaction [Line Items]
Right to receive common stock								1
Private Placement | Common Stock
Related Party Transaction [Line Items]
Sale of common stock, Shares							567,500
Over-Allotment Option
Related Party Transaction [Line Items]
Share price per share							$ 10
Sale of stock price per unit	$ 10
Number of additional units purchased by underwriters	2,250,000
Over-Allotment Option | Common Stock
Related Party Transaction [Line Items]
Sale of common stock, Shares							120,000
Sponsor and Northland Investment
Related Party Transaction [Line Items]
Sale of common stock, Shares			2,500,000
Proceeds from sale of common stock to Founders			$ 25,000
Share price per share			$ 0.01
Common stock, dividend					0.493
Shares, outstanding					3,732,500
EarlyBird
Related Party Transaction [Line Items]
Sale of common stock, Shares						68,041
Share price per share				$ 0.0067		$ 0.0067
Aggregate purchase price						$ 670
EarlyBird | Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued								29,900
EarlyBird Group
Related Party Transaction [Line Items]
Sale of common stock, Shares						31,959
Share price per share				$ 0.0067		$ 0.0067
Aggregate purchase price						$ 670
Sponsor, Northland Investment, EarlyBird and The EarlyBird Group Holding
Related Party Transaction [Line Items]
Common stock, dividend				0.1541
Shares, outstanding								4,307,500
Founders
Related Party Transaction [Line Items]
Share price per share							$ 0.005804
Founders | Private Placement
Related Party Transaction [Line Items]
Share price per share							$ 10
Aggregate number of shares issued		492,500
Sale of stock price per unit		$ 10
Founders | Private Placement | Second Closing of Offering
Related Party Transaction [Line Items]
Aggregate number of shares issued	75,000
Sale of stock price per unit	$ 10
Sponsor | Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued								481,250
Northland Investment | Private Placement
Related Party Transaction [Line Items]
Aggregate number of shares issued								56,350
Northland Investment | Private Underwriter Shares
Related Party Transaction [Line Items]
Aggregate number of shares issued		100,000
Sale of stock price per unit		$ 10
Northland Investment | Over-Allotment Option
Related Party Transaction [Line Items]
Aggregate number of shares issued	20,000
Sale of stock price per unit	$ 10
Sponsor Northland Investment And Early Bird | Private Placement
Related Party Transaction [Line Items]
Number of shares of common stock per unit								1
Common stock, par value								$ 0.0001
Sponsor Northland Investment And Early Bird | Private Placement | Rights
Related Party Transaction [Line Items]
Right to receive common stock								0.05
Sponsor Northland Investment And Early Bird | Private Placement | Warrants
Related Party Transaction [Line Items]
Right to receive common stock								1
Exercise price of warrants								$ 11.50
Over-Allotment Option
Related Party Transaction [Line Items]
Sale of stock price per unit	$ 10
Option to purchase additional units to cover over-allotments								2,250,000
Number of additional units purchased by underwriters	2,250,000
GigFounders, LLC | Office Space, Administrative Services and Secretarial Support
Related Party Transaction [Line Items]
Payment to affiliate of sponsor								$ 20,000

Commitments and Contingencies -

Commitments and Contingencies - Additional information (Details)	9 Months Ended
	Sep. 30, 2020
Commitments And Contingencies Disclosure [Abstract]
Business combination marketing agreement, underwriters fee percentage description	Pursuant to that agreement, the Company will pay the underwriters a cash fee for such services upon the consummation of its initial Business Combination in an amount equal to, in the aggregate, 3.5% of the gross proceeds of the Offering, including any proceeds from the exercise of the over-allotment options
Underwriters fee on gross proceeds of offering including over-allotment option percentage	3.50%

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($)	Aug. 12, 2019	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Jun. 10, 2019	Jun. 05, 2019	Mar. 05, 2019
Class Of Stock [Line Items]
Common stock, shares authorized		100,000,000		100,000,000
Common stock, shares issued		5,262,100		5,202,198
Common stock, shares outstanding		5,262,100		5,202,198
Preferred stock, shares authorized		1,000,000		1,000,000
Preferred stock, shares issued		0		0
Preferred stock, shares outstanding		0		0
Stock-based compensation expense		$ 0
Chief Financial Officer
Class Of Stock [Line Items]
Common stock, shares issued								5,000
Shared-based compensation arrangement by share-based payment award, option, nonvested options forfeited, number of shares	5,000
Rights
Class Of Stock [Line Items]
Period allotted to complete the business combination		18 months
Warrants or rights outstanding		17,817,500
Contractual penalties for failure to deliver securities to the rights holders		$ 0
Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized		100,000,000
Common stock, voting rights per share		Holders of the Company’s common stock are entitled to one vote for each share of common stock
Common stock, shares issued		5,262,100
Common stock, shares outstanding		5,262,100	5,229,076	5,202,198	5,215,163	5,237,624			0
Shares subject to possible redemption		16,982,900
Common Stock | Rights
Class Of Stock [Line Items]
Number of shares of common stock each holder receive		0.05
Common Stock | Maximum
Class Of Stock [Line Items]
Exercise price of warrants		$ 9.50
Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized		1,000,000
Preferred stock, shares issued		0
Preferred stock, shares outstanding		0
Warrants
Class Of Stock [Line Items]
Exercise price of warrants		$ 11.50					$ 11.50
Number of trading days required for warrant exercise price adjustment		20 days
Percentage of warrants exercise price		115.00%
Period after business combination when warrants become exercisable		30 days
Period after offering when warrants become exercisable		12 months
Warrants exercisable expiration period after completion of business combination		5 years
Period allotted to complete the business combination		18 months
Net cash settlement value of warrants		$ 0
Redemption price per warrant		$ 0.01
Minimum period of prior written notice of redemption of warrants		30 days
Minimum price per share required for redemption of warrants		$ 18
Warrants redemption covenant, threshold trading days		20 days
Warrants redemption covenant, threshold consecutive trading days		30 days
Warrants or rights outstanding		17,817,500
Warrants | Rights
Class Of Stock [Line Items]
Number of shares of common stock each holder receive							0.20
Warrants | Maximum
Class Of Stock [Line Items]
Exercise price of warrants		$ 9.50
Warrants | Minimum [Member]
Class Of Stock [Line Items]
Percentage of aggregate gross proceeds of equity issuances		60.00%

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Assets:
Cash and marketable securities held in Trust Account	$ 174,284,387	$ 173,994,583
Recurring Basis | Level 1
Assets:
Cash and marketable securities held in Trust Account	$ 174,284,387

Subsequent Events - Additional

Subsequent Events - Additional information (Details) - USD ($)	Dec. 10, 2020	Sep. 30, 2020	Nov. 11, 2020
Subsequent Event [Line Items]
Subsequent event, description		If the Extension Amendment proposal is not approved and the Company does not consummate a Business Combination by December 10, 2020, as contemplated by the Charter, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account deposits (which interest shall be net of taxes payable and after setting aside up to $100,000 to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Board, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our rights or warrants, which will expire worthless in the event the Company winds up.
Common Stock
Subsequent Event [Line Items]
Affirmative vote percentage		65.00%
Subsequent Event
Subsequent Event [Line Items]
Per share price of public redeemable share	$ 10.10
Closing price of the company's common stock			$ 10.08
Maximum
Subsequent Event [Line Items]
Net tangible assets		$ 5,000,001